Kornitzer Capital Management Inc. KS Cuts Position in InMode Ltd. (NASDAQ:INMD)

Kornitzer Capital Management Inc. KS lessened its stake in InMode Ltd. (NASDAQ:INMD) by 25.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,070 shares of the healthcare company’s stock after selling 3,505 shares during the quarter. Kornitzer Capital Management Inc. KS’s holdings in InMode were worth $168,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Nisa Investment Advisors LLC increased its holdings in shares of InMode by 314.7% in the 3rd quarter. Nisa Investment Advisors LLC now owns 3,550 shares of the healthcare company’s stock valued at $60,000 after purchasing an additional 2,694 shares in the last quarter. Quarry LP increased its holdings in shares of InMode by 154.3% in the 3rd quarter. Quarry LP now owns 3,781 shares of the healthcare company’s stock valued at $64,000 after purchasing an additional 2,294 shares in the last quarter. National Bank of Canada FI increased its holdings in shares of InMode by 6.2% in the 3rd quarter. National Bank of Canada FI now owns 9,985 shares of the healthcare company’s stock valued at $169,000 after purchasing an additional 579 shares in the last quarter. GW Henssler & Associates Ltd. purchased a new position in shares of InMode in the 3rd quarter valued at about $177,000. Finally, DGS Capital Management LLC purchased a new position in shares of InMode in the 3rd quarter valued at about $182,000. Hedge funds and other institutional investors own 68.04% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on INMD shares. Barclays increased their price objective on shares of InMode from $26.00 to $29.00 and gave the company an “overweight” rating in a research note on Wednesday, February 5th. Needham & Company LLC reissued a “hold” rating on shares of InMode in a research note on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, InMode presently has an average rating of “Hold” and an average price target of $22.25.

InMode Trading Up 1.5 %

Shares of NASDAQ INMD opened at $19.40 on Thursday. The stock has a market cap of $1.35 billion, a price-to-earnings ratio of 8.26 and a beta of 2.13. InMode Ltd. has a 52 week low of $14.87 and a 52 week high of $23.46. The company’s 50-day moving average price is $17.36 and its 200 day moving average price is $17.26.

InMode Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.